News on Lambda from BioPortfolio.com http://www.BioPortfolio.com Consolidated Lambda news from BioPortfolio.com Wed, 10 Feb 2010 13:44:42 GMT en ZymoGenetics to Host Conference Call and Webcast on February 11, 2010 to Discuss 2009 Year-end Financial Resulhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016441&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016441&THISHREF=http://c.moreover.com/click/here.pl%3fz2524765429%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016441&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016441&THISHREF=http://c.moreover.com/click/here.pl%3fz2524765429%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Dynavax Technologies to present data on its SD-101 Phase 1b trial for chronic HCV infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967558&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967558&THISHREF=http://c.moreover.com/click/here.pl%3fz2499792571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967558&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967558&THISHREF=http://c.moreover.com/click/here.pl%3fz2499792571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971338&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971338&THISHREF=http://c.moreover.com/click/here.pl%3fz2501813655%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971338&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971338&THISHREF=http://c.moreover.com/click/here.pl%3fz2501813655%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970046&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970046&THISHREF=http://c.moreover.com/click/here.pl%3fz2501142850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970046&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970046&THISHREF=http://c.moreover.com/click/here.pl%3fz2501142850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Dynavax gets positive data for Hep C trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968342&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968342&THISHREF=http://c.moreover.com/click/here.pl%3fz2500311507%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968342&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968342&THISHREF=http://c.moreover.com/click/here.pl%3fz2500311507%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: Dynavax Reports Positive Phase 1b Data For Chronic Hepatitis C Infection Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967425&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967425&THISHREF=http://c.moreover.com/click/here.pl%3fz2499714624%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967425&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967425&THISHREF=http://c.moreover.com/click/here.pl%3fz2499714624%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Business Review: DVAX.NASDAQ Profiles for January 26, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967301&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967301&THISHREF=http://c.moreover.com/click/here.pl%3fz2499586613%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967301&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967301&THISHREF=http://c.moreover.com/click/here.pl%3fz2499586613%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Dynavax drug candidate against HCV infection shows positive results in studieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967300&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967300&THISHREF=http://c.moreover.com/click/here.pl%3fz2499586456%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967300&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967300&THISHREF=http://c.moreover.com/click/here.pl%3fz2499586456%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965211&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965211&THISHREF=http://c.moreover.com/click/here.pl%3fz2498421102%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965211&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965211&THISHREF=http://c.moreover.com/click/here.pl%3fz2498421102%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Dynavax Technologies Corporation (DVAX) Hepatitis C Drug Shows Promise in Phase 1 Trial; Shares Soarhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966570&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966570&THISHREF=http://c.moreover.com/click/here.pl%3fz2499085055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966570&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966570&THISHREF=http://c.moreover.com/click/here.pl%3fz2499085055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962683&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962683&THISHREF=http://c.moreover.com/click/here.pl%3fz2497424395%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962683&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962683&THISHREF=http://c.moreover.com/click/here.pl%3fz2497424395%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Dynavax shares jump on promising hep C datahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966624&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966624&THISHREF=http://c.moreover.com/click/here.pl%3fz2499126209%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966624&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966624&THISHREF=http://c.moreover.com/click/here.pl%3fz2499126209%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFierceBiotech: Small Cap Stocks to Watch - DVAX, ACHN, GLBL, MRNAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966288&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966288&THISHREF=http://c.moreover.com/click/here.pl%3fz2498959280%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966288&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966288&THISHREF=http://c.moreover.com/click/here.pl%3fz2498959280%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: SmallCapReview Initiates Coverage of Dynavax Technologies (DVAX) and Achillion Pharmaceuticals (ACHN)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3963801&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3963801&THISHREF=http://c.moreover.com/click/here.pl%3fz2497866516%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3963801&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3963801&THISHREF=http://c.moreover.com/click/here.pl%3fz2497866516%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962741&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962741&THISHREF=http://c.moreover.com/click/here.pl%3fz2497442557%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962741&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lambda&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962741&THISHREF=http://c.moreover.com/click/here.pl%3fz2497442557%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: